UFF
UTHR icon

USA Financial Formulas’s United Therapeutics UTHR Stock Holding History

USA Financial Formulas’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$593 Hold
1
– – ﹤0.01% 373
2025
Q4 		$487 Buy
+1
New +$466 ﹤0.01% 379
2025
Q1 		– Sell
-870
Closed -$307K – 369
2024
Q4 		$307K Buy
870
+779
+856% +$286K 0.05% 127
2024
Q3 		$32.6K Buy
+91
New +$30.7K 0.01% 229
2023
Q4 		– Sell
-227
Closed -$51.3K – 551
2023
Q3 		$51.3K Hold
227
– – 0.08% 202
2023
Q2 		$50.1K Sell
227
-17
-7% -$3.77K 0.08% 167
2023
Q1 		$54.6K Buy
+244
New +$60.2K 0.09% 124
2020
Q3 		– Sell
-4,384
Closed -$530K – 364
2020
Q2 		$530K Buy
+4,384
New +$493K 0.39% 46
2015
Q2 		– Sell
-3,167
Closed -$546K – 280
2015
Q1 		$546K Buy
+3,167
New +$483K 0.18% 92

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

USA Financial Formulas's UTHR Position: Q1 2026 in Review

USA Financial Formulas held its United Therapeutics (UTHR) position steady in Q1 2026 at 1 share worth $593. The position accounts for ﹤0.01% of the portfolio, ranked #373.

USA Financial Formulas first reported a position in UTHR in Q1 2015 and has held it in 9 quarters since. The position peaked at $546K in Q1 2015. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • USA Financial Formulas held 1 share of United Therapeutics worth $593 as of Q1 2026.
  • USA Financial Formulas left its United Therapeutics share count unchanged in Q1 2026.
  • United Therapeutics made up ﹤0.01% of USA Financial Formulas's portfolio in Q1 2026, its #373 holding.
  • USA Financial Formulas first reported a position in United Therapeutics in Q1 2015 and has held it in 9 quarters since.
  • USA Financial Formulas's United Therapeutics position peaked at $546K in Q1 2015.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.